Skip to content
value.today

Cardiosolutions Inc.

Total raised
$15 M
1 round on record
Latest round
$15 M
Jul 2012
First round on record
Jul 2012
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cardiosolutions Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2012$15 MNo. 1$10 to $50 million

Cardiosolutions Inc.: Raise no. 1, Jul 2012

Investors in this round

49 investors had bought by the notice of Jul 19, 2012: 49 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$467,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jon J. Wilson · Executive Officer
  • Ross J. Garofalo · Executive Officer
  • Steven J. Tallarida · Executive Officer, Director
  • Andrea J. Patisteas · Director
  • Craig J. Walker · Director
  • Kenneth J. Eliasen · Director
  • Marc J. Goldberg · Director
  • Michael J. Benoit · Director
  • Richard J. Granger · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Healthios Capital Markets LLC (CRD 115542) · broker-dealer Healthios Capital Markets LLC (CRD 115542) · Northbrook, IllinoisSold in CO

Remarks in the notice

  • On fees: “Plus 312,720 shares of Series B Convertible Preferred Stock”
  • On the amounts: “Includes $6,880,212 of conversion of convertible debt.”

Signed by Ross J. Garofalo, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 19, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cardiosolutions Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2012).

    SEC Form D · Jul 2012

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2012

That is all the official record says: Cardiosolutions Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cardiosolutions Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 49 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cardiosolutions Inc.
NameRoleNamed in
Jon J. WilsonExecutive officerJul 2012
Ross J. GarofaloExecutive officerJul 2012
Steven J. TallaridaExecutive officerJul 2012
Andrea J. PatisteasDirectorJul 2012
Craig J. WalkerDirectorJul 2012
Kenneth J. EliasenDirectorJul 2012
Marc J. GoldbergDirectorJul 2012
Michael J. BenoitDirectorJul 2012
Richard J. GrangerDirectorJul 2012
Steven J. TallaridaDirectorJul 2012